Covalent binding of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline to albumin and hemoglobin at environmentally relevant doses. Comparison of human subjects and F344 rats.

Covalent binding of the food-borne heterocyclic amine 2-amino-3, 8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) to albumin and hemoglobin (Hb), 3.5-6.0 hr after oral administration of a single dose of either 21.3 or 228.0 microg of [14C]MeIQx (304 and 3257 ng/kg of body weight, respectively, based on a 70-kg subject weight), was studied in human volunteers using accelerator mass spectrometry. Human protein adduct levels were compared with data obtained for male F344 rats 4.5 hr after oral administration of 0.94-11,420 ng/kg of body weight [14C]MeIQx. Dose-dependent levels of MeIQx-albumin and MeIQx-Hb adducts were detected in both humans and rats. In each case, the regression coefficient (slope) of the dose-response curve was approximately 1. The highest levels of adduct formation per unit dose of MeIQx occurred with human albumin, followed by rat albumin, human Hb, and rat Hb (in that order). Although the human subjects were elderly and underwent colon resection surgery during the study period, the results indicate that formation of albumin and Hb adducts is dose dependent and that a trend exists for higher adduct levels per unit dose in humans, compared with F344 rats. Furthermore, MeIQx-albumin adducts are likely to provide a more sensitive marker of exposure to MeIQx than are MeIQx-Hb adducts.

[1]  F. Perera.  The significance of DNA and protein adducts in human biomonitoring studies. , 1988, Mutation research.

[2]  L. Cohen.  Diet and cancer. , 1987, Scientific American.

[3]  A. Ronco,et al.  Meat intake, heterocyclic amines, and risk of breast cancer: a case-control study in Uruguay. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[4]  J. Vogel,et al.  Biomedical accelerator mass spectrometry , 1995 .

[5]  C. Wild,et al.  Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats. , 1986, Carcinogenesis.

[6]  F. Kadlubar,et al.  Species differences in the biotransformation of the food-borne carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine by hepatic microsomes and cytosols from humans, rats, and mice. , 1995, Drug metabolism and disposition: the biological fate of chemicals.

[7]  T. Sugimura,et al.  Determination of human exposure to the dietary carcinogen 3-amino-1, 4-dimethyl-5H-pyrido[4,3-b]indole (Trp-P-1) from hemoglobin adduct: the relationship to DNA adducts. , 1992, Carcinogenesis.

[8]  M. Butler,et al.  Metabolic activation of carcinogenic heterocyclic aromatic amines by human liver and colon. , 1991, Carcinogenesis.

[9]  S. Tannenbaum,et al.  Protein adducts in the molecular dosimetry of chemical carcinogens. , 1990, Carcinogenesis.

[10]  F. Hatch,et al.  Heterocyclic amine mutagenicity/carcinogenicity: influence of repair, metabolism, and structure. , 1995, Princess Takamatsu symposia.

[11]  M A Butler,et al.  Rapid metabolic phenotypes for acetyltransferase and cytochrome P4501A2 and putative exposure to food-borne heterocyclic amines increase the risk for colorectal cancer or polyps. , 1994, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[12]  A. Boobis,et al.  Molecular dosimetry of the food-borne carcinogen MeIQx using adducts of serum albumin. , 1993, Carcinogenesis.

[13]  A. Boobis,et al.  The measurement of MeIQx adducts with mouse haemoglobin in vitro and in vivo: implications for human dosimetry. , 1991, Carcinogenesis.

[14]  T. Sugimura,et al.  Food-derived mutagens and carcinogens. , 1992, Cancer research.

[15]  A. Agresti,et al.  Categorical Data Analysis , 1991, International Encyclopedia of Statistical Science.

[16]  J. Southon,et al.  Accelerator mass spectrometry in biomedical dosimetry: relationship between low-level exposure and covalent binding of heterocyclic amine carcinogens to DNA. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[17]  R. Sinha,et al.  Risk of adenocarcinoma of the stomach and esophagus with meat cooking method and doneness preference , 1997, International journal of cancer.

[18]  S. Tannenbaum,et al.  Binding of 2-amino-3-methylimidazo[4,5-f]quinoline to hemoglobin and albumin in vivo in the rat. Identification of an adduct suitable for dosimetry. , 1987, Carcinogenesis.

[19]  H. Ohgaki,et al.  Carcinogenicity in rats of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline. , 1988, Carcinogenesis.

[20]  G. Steineck,et al.  Meat, cooking methods and colorectal cancer: A case‐referent study in Stockholm , 1991, International journal of cancer.

[21]  William Francis Ganong,et al.  Review of Medical Physiology , 1969 .

[22]  K T Bogen,et al.  Cancer risk of heterocyclic amines in cooked foods: an analysis and implications for research. , 1995, Carcinogenesis.

[23]  T. Sugimura,et al.  Presence of carcinogenic heterocyclic amines in urine of healthy volunteers eating normal diet, but not of inpatients receiving parenteral alimentation. , 1991, Carcinogenesis.

[24]  大垣 比呂子.  Carcinogenicity in mice of a mutagenic compound, 2-amino-3-methylimidazo[4,5-f]quinoline, from broiled sardine, cooked beef and beef extract , 1986 .

[25]  D. Schmähl,et al.  Diet and cancer , 2004, Journal of Cancer Research and Clinical Oncology.

[26]  H. Ohgaki,et al.  Carcinogenicity in mice of a mutagenic compound, 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) from cooked foods. , 1987, Carcinogenesis.

[27]  F. Plum.  Handbook of Physiology. , 1960 .